Gene · 201161
CENPV: centromere protein V
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. CENPV: centromere protein V. Genes, record 201161. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/201161
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q7Z7K6 | Centromere protein V | 275 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents4
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,000
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CENPV papers | Newest fiscal year |
|---|---|---|---|
| P01CA100730 | Retrovirus Models of Cancer | 18 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| ZIABC005645 | Role of the HTLV-1A and HTLV1-C inflammatory profile in disease | 7 | 2025 |
| ZIANS002817 | Involvement Of Human Viruses Associated With Chronic Neurologic Disease | 6 | 2025 |
| T32AI089474 | Immunology Training Program-Predoctoral | 5 | 2025 |
| ZIABC011325 | Retrovirus Biology | 5 | 2025 |
| ZIANS003040 | Translational studies of human viruses and chronic neurologic disease | 5 | 2025 |
| P30AI036214 | San Diego Center for AIDS Research (SD CFAR) | 4 | 2025 |
| P30AI050410 | The University of North Carolina Center for AIDS Research | 3 | 2025 |
1 to 10 of 1,000Source NIH's project files
See all 1,000 nih grantsPapers1,956
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Silent Vehicle: Validating the Biological Signals and Noises of Baculovirus Vectors in Macrophage-Targeted Vaccines. | Vaccines (Basel) | 2026 | 42797636 | PubTator, text mining | PubMed |
| Development and Evaluation of Three Indirect ELISA Methods Based on Novel Recombinant ASFV Antigens for Serological Detection of African Swine Fever. | Pathogens | 2026 | 42796751 | PubTator, text mining | PubMed |
| Evaluating the persistence of semen under controlled environmental conditions. | Sci Justice | 2026 | 42680473 | PubTator, text mining | PubMed |
| PROFET predicts continuous gene expression dynamics from scRNA-seq data to elucidate heterogeneity of cancer treatment responses. | Cell Syst | 2026 | 42664975 | PubTator, text mining | PubMed |
| Human CEBPA -N AML exhibits enhanced engraftment and a C/EBP α -p30-driven leukemic stem cell program. | bioRxiv | 2026 | 42620173 | PubTator, text mining | PubMed |
| Identification of three novel overlapping epitopes within the immunodominant region of ASFV p30 protein facilitates development of a competitive ELISA for antibody detection. | Virology | 2026 | 42430997 | PubTator, text mining | PubMed |
| Towards a neurophysiological diagnostic marker of Alzheimer's disease using transcranial magnetic stimulation combined with electroencephalography. | J Alzheimers Dis | 2026 | 42417152 | PubTator, text mining | PubMed |
| MGF100 but not MGF300 family is a potential multigene-deleted target for ASFV attenuation and live attenuated vaccine development. | Virulence | 2026 | 42406513 | PubTator, text mining | PubMed |
| Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins. | Vaccines (Basel) | 2026 | 42347635 | PubTator, text mining | PubMed |
| Identification of human T lymphotropic virus type-1 p30 protein phosphorylations and computational analysis of their effect on intrinsically disordered nature of p30. | J Biomol Struct Dyn | 2026 | 42323837 | PubTator, text mining | PubMed |
1 to 10 of 1,956
See all 1,956 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/201161
GET https://conductscience.org/api/genes/v1/201161/grants?page=2